Structure and function of the selectin ligand PSGL-1
- PMID: 10412562
- DOI: 10.1590/s0100-879x1999000500004
Structure and function of the selectin ligand PSGL-1
Abstract
P-selectin glycoprotein ligand-1 (PSGL-1) is a dimeric mucin-like 120-kDa glycoprotein on leukocyte surfaces that binds to P- and L-selectin and promotes cell adhesion in the inflammatory response. The extreme amino terminal extracellular domain of PSGL-1 is critical for these interactions, based on site-directed mutagenesis, blocking monoclonal antibodies, and biochemical analyses. The current hypothesis is that for high affinity interactions with P-selectin, PSGL-1 must contain O-glycans with a core-2 branched motif containing the sialyl Lewis x antigen (NeuAc alpha 2-->3Gal beta 1-->4[Fuc alpha 1-->3]GlcNAc beta 1-->R). In addition, high affinity interactions require the co-expression of tyrosine sulfate on tyrosine residues near the critical O-glycan structure. This review addresses the biochemical evidence for this hypothesis and the evidence that PSGL-1 is an important in vivo ligand for cell adhesion.
Similar articles
-
Model glycosulfopeptides from P-selectin glycoprotein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin.J Biol Chem. 2003 Jul 18;278(29):26391-400. doi: 10.1074/jbc.M303551200. Epub 2003 May 7. J Biol Chem. 2003. PMID: 12736247
-
Tyrosine sulfation enhances but is not required for PSGL-1 rolling adhesion on P-selectin.Biophys J. 2001 Oct;81(4):2001-9. doi: 10.1016/S0006-3495(01)75850-X. Biophys J. 2001. PMID: 11566773 Free PMC article.
-
A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to P-selectin.J Biol Chem. 1999 Aug 27;274(35):24838-48. doi: 10.1074/jbc.274.35.24838. J Biol Chem. 1999. PMID: 10455156
-
Structure and function of P-selectin glycoprotein ligand-1.Leuk Lymphoma. 1998 Mar;29(1-2):1-15. doi: 10.3109/10428199809058377. Leuk Lymphoma. 1998. PMID: 9638971 Review.
-
PSGL-1 function in immunity and steady state homeostasis.Immunol Rev. 2009 Jul;230(1):75-96. doi: 10.1111/j.1600-065X.2009.00797.x. Immunol Rev. 2009. PMID: 19594630 Review.
Cited by
-
PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy.Front Immunol. 2021 Feb 23;12:636238. doi: 10.3389/fimmu.2021.636238. eCollection 2021. Front Immunol. 2021. PMID: 33708224 Free PMC article. Review.
-
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma.Nat Commun. 2021 Mar 5;12(1):1453. doi: 10.1038/s41467-021-21774-4. Nat Commun. 2021. PMID: 33674603 Free PMC article.
-
Staphylococcus aureus Causes the Arrest of Neutrophils in the Bloodstream in a Septicemia Model.Microorganisms. 2022 Aug 24;10(9):1696. doi: 10.3390/microorganisms10091696. Microorganisms. 2022. PMID: 36144298 Free PMC article.
-
Adhesion of Toxoplasma gondii tachyzoite-infected vehicle leukocytes to capillary endothelial cells triggers timely parasite egression.Sci Rep. 2017 Jul 18;7(1):5675. doi: 10.1038/s41598-017-05956-z. Sci Rep. 2017. PMID: 28720868 Free PMC article.
-
PSGL-1 from the murine leukocytic cell line WEHI-3 is enriched for core 2-based O-glycans with sialyl Lewis x antigen.Glycobiology. 2008 Jun;18(6):441-6. doi: 10.1093/glycob/cwn020. Epub 2008 Feb 29. Glycobiology. 2008. PMID: 18310305 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources